BIOMAT Database Logo BIOMAT Database Logo

Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. 1997

T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.

Human platelet glycoprotein Ib/IX complex acts as a receptor for von Willebrand factor. It is widely accepted that glycoprotein Ib is the essential receptor component, but the role of glycoprotein IX is still unclear. We produced a new monoclonal anti-glycoprotein IX antibody (KMP-9) by the hybridoma technique using platelets from a patient with Glanzmann's thrombasthenia. The epitope of KMP-9 was localized to the C-terminal 8 kD fragment of glycoprotein IX using ELISA analysis of polyethylene-pin-synthesized peptides, as well as Western blot analysis of platelets after digestion with N-glycosidase and Staphylococcus aureus V8 protease. KMP-9 partially inhibited high shear stress-induced platelet aggregation, but had no effect on aggregation induced by ristocetin or low shear stress. Its inhibitory effect on high shear stress-induced aggregation was weaker than that of anti-glycoprotein Ib or anti-glycoprotein IIb/IIIa monoclonal antibodies. A 21-mer synthetic peptide (glycoprotein IX L110-G130) inhibited the binding of KMP-9 to platelets. It also competively inhibited the suppression of high shear stress-induced platelet aggregation by KMP-9, but had no direct effect on this aggregation. KMP-9 may be useful to clarify the physiological role of GPIX.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013314 Stress, Mechanical A purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area. Mechanical Stress,Mechanical Stresses,Stresses, Mechanical
D019038 Platelet Glycoprotein GPIb-IX Complex Platelet membrane glycoprotein complex essential for normal platelet adhesion and clot formation at sites of vascular injury. It is composed of three polypeptides, GPIb alpha, GPIb beta, and GPIX. Glycoprotein Ib functions as a receptor for von Willebrand factor and for thrombin. Congenital deficiency of the GPIb-IX complex results in Bernard-Soulier syndrome. The platelet glycoprotein GPV associates with GPIb-IX and is also absent in Bernard-Soulier syndrome. Antigens, CD42a,Antigens, CD42b,Antigens, CD42c,Antigens, CD42d,CD42a Antigens,CD42b Antigens,CD42c Antigens,CD42d Antigens,Platelet Membrane Glycoprotein IX,Platelet Membrane Glycoprotein Ib,Platelet Membrane Glycoprotein V,CD42a Antigen,CD42b Antigen,CD42c Antigen,CD42d Antigen,Glycoprotein Ib,Glycoprotein Ib alpha,Glycoprotein Ib beta,Glycoprotein Ib-IX Complex,Platelet Glycoprotein IX,Antigen, CD42a,Antigen, CD42b,Antigen, CD42c,Antigen, CD42d,Glycoprotein Ib IX Complex,Platelet Glycoprotein GPIb IX Complex

Related Publications

T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
Glycoprotein Ib/IX/V binding to the membrane skeleton maintains shear-induced platelet aggregation.
April 2001, Thrombosis research,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
[Effects of anti-platelet agents on shear-induced platelet aggregation].
June 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
A monoclonal antibody to platelet glycoprotein IIb induces aggregation of platelet rich plasma.
January 1990, Haematologica,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
April 1997, Biochemical and biophysical research communications,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
Effects of ticlopidine on monoclonal anti-CD9 antibody-induced platelet aggregation and microparticle generation.
January 1992, Thrombosis research,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
Enhancing effect by heparin on shear-induced platelet aggregation.
October 1990, Seminars in thrombosis and hemostasis,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
Further characterization of anti-platelet monoclonal antibody HPL5 as anti-glycoprotein V antibody.
January 2006, Acta haematologica,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes.
April 1999, Arteriosclerosis, thrombosis, and vascular biology,
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
Shear-induced platelet aggregation.
March 1990, Lancet (London, England),
T Miyake, and S Nomura, and Y Komiyama, and Y Miyazaki, and H Kagawa, and M Masuda, and H Takahashi, and Y Fujimura, and Y Ikeda, and S Fukuhara
Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
September 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Copied contents to your clipboard!